These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33925005)

  • 1. Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.
    Ida Y; Watanabe M; Ohguro H; Hikage F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.
    Ida Y; Watanabe M; Umetsu A; Ohguro H; Hikage F
    Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102315. PubMed ID: 34246925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.
    Ichioka H; Ida Y; Watanabe M; Ohguro H; Hikage F
    Exp Eye Res; 2021 Apr; 205():108489. PubMed ID: 33587909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells.
    Ida Y; Hikage F; Umetsu A; Ida H; Ohguro H
    Sci Rep; 2020 Sep; 10(1):16018. PubMed ID: 32994409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Effects of a Selective EP2 Agonist, Omidenepag, and a Rho-Associated Coiled-Coil Containing Protein Kinase Inhibitor, Ripasudil, on Human Orbital Fibroblasts.
    Hikage F; Watanabe M; Sato T; Umetsu A; Tsugeno Y; Furuhashi M; Ohguro H
    J Ocul Pharmacol Ther; 2023 Sep; 39(7):439-448. PubMed ID: 37352418
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin F2 and EP2 Agonists Exert Different Effects on 3D 3T3-L1 Spheroids during Their Culture Phase.
    Ida Y; Furuhashi M; Watanabe M; Umetsu A; Hikage F; Ohguro H
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).
    Hikage F; Ichioka H; Watanabe M; Umetsu A; Ohguro H; Ida Y
    Hum Cell; 2022 Jan; 35(1):125-132. PubMed ID: 34591280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.
    Ida Y; Ichioka H; Furuhashi M; Hikage F; Watanabe M; Umetsu A; Ohguro H
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROCK inhibitors enhance the production of large lipid-enriched 3D organoids of 3T3-L1 cells.
    Ida Y; Hikage F; Ohguro H
    Sci Rep; 2021 Mar; 11(1):5479. PubMed ID: 33750898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
    Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexpected Crosslinking Effects of a Human Thyroid Stimulating Monoclonal Autoantibody, M22, with IGF1 on Adipogenesis in 3T3L-1 Cells.
    Umetsu A; Sato T; Watanabe M; Ida Y; Furuhashi M; Tsugeno Y; Ohguro H
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts.
    Hikage F; Ida Y; Ouchi Y; Watanabe M; Ohguro H
    Transl Vis Sci Technol; 2021 Apr; 10(4):6. PubMed ID: 34003984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROCK inhibitors modulate the physical properties and adipogenesis of 3D spheroids of human orbital fibroblasts in different manners.
    Hikage F; Ichioka H; Watanabe M; Umetsu A; Ohguro H; Ida Y
    FASEB Bioadv; 2021 Oct; 3(10):866-872. PubMed ID: 34632320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM).
    Ota C; Ida Y; Ohguro H; Hikage F
    Sci Rep; 2020 Nov; 10(1):20292. PubMed ID: 33219246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells.
    Umetsu A; Ida Y; Sato T; Watanabe M; Tsugeno Y; Furuhashi M; Hikage F; Ohguro H
    Bioengineering (Basel); 2022 Jul; 9(7):. PubMed ID: 35877378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EP2 agonist, omidenepag, alters the physical stiffness of 3D spheroids prepared from human corneal stroma fibroblasts differently depending on the osmotic pressure.
    Ida Y; Umetsu A; Furuhashi M; Watanabe M; Hikage F; Ohguro H
    FASEB J; 2022 Jan; 36(1):e22067. PubMed ID: 34914140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.
    Oouchi Y; Watanabe M; Ida Y; Ohguro H; Hikage F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of ROCK Inhibitors Alleviates Prostaglandin-Induced Inhibition of Adipogenesis in 3T3L-1 Spheroids.
    Ida Y; Sato T; Umetsu A; Watanabe M; Furuhashi M; Hikage F; Ohguro H
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36421103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells.
    Watanabe M; Ida Y; Furuhashi M; Tsugeno Y; Ohguro H; Hikage F
    Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.
    Fuwa M; Shimazaki A; Odani-Kawabata N; Kirihara T; Taniguchi T; Iwamura R; Yoneda K; Kato M; Morishima K; Shams NK
    J Ocul Pharmacol Ther; 2021 May; 37(4):223-229. PubMed ID: 33600237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.